When family history holds the clue: delayed diagnosis of spinal muscular atrophy type 3 in a 12-year-old boy – a case report

Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disorder caused by biallelic abnormalities of the survival motor neuron 1 (SMN1) gene, with phenotype modified in part by SMN2 copy number. The estimated incidence is approximately 1 in 10,000 live births, although estimates vary between populations. SMA type 3 presents after independent walking has been achieved and may cause progressive proximal weakness, falls, difficulty rising from the floor, and gait abnormalities. Delayed diagnosis remains clinically relevant despite the availability of molecular testing and disease-modifying therapies. Published reports have described children initially managed for hypotonia, gait abnormalities, orthopedic problems, or other neuromuscular diagnoses before SMA was recognized. This case is publishable because it combines several educationally important features. The diagnostic delay following an initial orthopedic label of bilateral club feet, despite having a similarly affected older sibling, indicate the lack of knowledge and clinical correlation. It therefore illustrates a clinically relevant diagnostic pathway, particularly for resource-limited settings, rather than simply documenting a rare genetic result. This article report a 12-year-old boy who had progressive difficulty walking since the age of 18 months, after achieving independent walking. He initially fell after walking short distances and developed difficulty rising from sitting, followed by difficulty climbing stairs, running, and jumping as his age progresses. At about 3 years he was reportedly diagnosed with bilateral club feet and treated with corrective shoes without improvement. Follow-up was later interrupted due to lack of improvement. The mother mentioned that the patient use his hands to crawl and stand. His 27-year-old brother had a similar early-onset progressive motor disorder and became wheelchair dependent. Examination showed exaggerated lumbar lordosis, generalized hypotonia, absent deep tendon reflexes, proximal lower-limb weakness with preserved distal strength, waddling gait, positive Gowers sign, and tongue fasciculation without atrophy. Sensation was intact. EMG showed mixed neurogenic and myogenic changes and NCS severe bilateral tibial axonal neuropathy. Molecular testing demonstrated homozygous deletion of SMN1 exon 7 and heterozygous deletion of exon 8, supporting 5q SMA, clinically consistent with SMA type 3. This case report shows that physicians should consider SMA in patients presented with progressive gait difficulty after acquisition of independent walking, especially when accompanied by proximal weakness, hypotonia, areflexia, Gowers sign and preserved sensation. Early recognition and molecular confirmation are increasingly important because disease-modifying therapies and multidisciplinary care have changed SMA management.

Authors

Publication Details

Journal
BMC Pediatrics
Published
2026-11-19
DOI
https://doi.org/10.1186/s12887-026-08018-4
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

When family history holds the clue: delayed diagnosis of spinal muscular atrophy type 3 in a 12-year-old boy – a case report

Tinsae Zelalem Amare, Eden Fekade Megen, Bereket Zelalem, Tamirat A
3 links
BMC Pediatrics
Neurogenetic and Muscular Disorders Research
article

When family history holds the clue: delayed diagnosis of spinal muscular atrophy type 3 in a 12-year-old boy – a case report

Tinsae Zelalem Amare, Eden Fekade Megen, Bereket Zelalem, Tamirat A
article en

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disorder caused by biallelic abnormalities of the survival motor neuron 1 (SMN1) gene, with phenotype modified in part by SMN2 copy number. The estimated incidence is approximately 1 in 10,000 live births, although estimates vary between populations. SMA type 3 presents after independent walking has been achieved and may cause progressive proximal weakness, falls, difficulty rising from the floor, and gait abnormalities. Delayed diagnosis remains clinically relevant despite the availability of molecular testing and disease-modifying therapies. Published reports have described children initially managed for hypotonia, gait abnormalities, orthopedic problems, or other neuromuscular diagnoses before SMA was recognized. This case is publishable because it combines several educationally important features. The diagnostic delay following an initial orthopedic label of bilateral club feet, despite having a similarly affected older sibling, indicate the lack of knowledge and clinical correlation. It therefore illustrates a clinically relevant diagnostic pathway, particularly for resource-limited settings, rather than simply documenting a rare genetic result. This article report a 12-year-old boy who had progressive difficulty walking since the age of 18 months, after achieving independent walking. He initially fell after walking short distances and developed difficulty rising from sitting, followed by difficulty climbing stairs, running, and jumping as his age progresses. At about 3 years he was reportedly diagnosed with bilateral club feet and treated with corrective shoes without improvement. Follow-up was later interrupted due to lack of improvement. The mother mentioned that the patient use his hands to crawl and stand. His 27-year-old brother had a similar early-onset progressive motor disorder and became wheelchair dependent. Examination showed exaggerated lumbar lordosis, generalized hypotonia, absent deep tendon reflexes, proximal lower-limb weakness with preserved distal strength, waddling gait, positive Gowers sign, and tongue fasciculation without atrophy. Sensation was intact. EMG showed mixed neurogenic and myogenic changes and NCS severe bilateral tibial axonal neuropathy. Molecular testing demonstrated homozygous deletion of SMN1 exon 7 and heterozygous deletion of exon 8, supporting 5q SMA, clinically consistent with SMA type 3. This case report shows that physicians should consider SMA in patients presented with progressive gait difficulty after acquisition of independent walking, especially when accompanied by proximal weakness, hypotonia, areflexia, Gowers sign and preserved sensation. Early recognition and molecular confirmation are increasingly important because disease-modifying therapies and multidisciplinary care have changed SMA management.

BMC Pediatrics
Good health and well-being
Neurogenetic and Muscular Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon